BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wu CQ, Zhou X, Li CP, He QL, Chen ZH, Ding SB, Deng L, Chen LL, Jiang K, Dong CK, Hu L, Zhu GB, Zhang CG, Zhang Y, Wu LL, Li W, Mao YH, Zhang H, Ai X, He YQ, Ma Y, He SY. Regional multi-center randomized trial of three vonoprazan-amoxicillin dosing regimens for Helicobacter pylori eradication in Sichuan Province, China. World J Gastroenterol 2025; 31(47): 114377 [PMID: 41479756 DOI: 10.3748/wjg.v31.i47.114377]
URL: https://www.wjgnet.com/1007-9327/full/v31/i47/114377.htm
Number Citing Articles
1
Tian-Qi Liu, Kang-Ning Li, Qing Chen. From clinical efficacy to population health: Implementing vonoprazan-amoxicillin dual therapy for <i>Helicobacter pylori</i> controlWorld Journal of Gastroenterology 2026; 32(12): 116953 doi: 10.3748/wjg.v32.i12.116953